Navigation Links
Oramed Pharmaceuticals Announces Filing of Two Registration Statements
Date:1/11/2010

JERUSALEM, Israel, January 11 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today announced that it has filed two registration statements on Form S-1 with the Securities and Exchange Commission.

One registration statement relates to a proposed public offering by Oramed of 24 million shares of common stock and warrants to purchase 12 million shares of common stock, as well as warrants to purchase up to approximately 2.5 million shares of common stock issuable to the placement agent of the offering.

This offering shall be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from Oramed. The registration statement may be accessed through the SEC's website at http://www.sec.gov.

Oramed expects to use the net proceeds from the offering to fund its planned research and development activities, as well as some other general and administrative costs.

The second filing is a shelf registration statement relating to a resale offering by certain Oramed stockholders of approximately 8.5 million shares of common stock and approximately 4.8 million shares of common stock issuable upon the exercise of warrants held by stockholders of Oramed who purchased such securities in private placement transactions.

This press release is made in accordance with Rule 135 under the Securities Act. Registration statements relating to these securities have been filed with the Securities and Exchange Commission but have not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the applicable re
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
2. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
3. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
4. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
5. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
6. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
7. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
8. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
9. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE ... announced underwritten public offering of 3,636,364 shares of its ... $2.75 per share. BioPharmX has granted the underwriters a ... of common stock at the public offering price. ... Fund, an existing stockholder, has agreed to purchase 1,081,081 ...
(Date:7/1/2015)... 2015 The global mHealth ... USD 49,119.2 million by 2020, according to a new ... expected to remain the dominant and fastest growing market ... 2012, and an estimated CAGR of 49.7% from 2014 ... , Browse full research report with TOC ...
(Date:7/1/2015)... , July 1, 2015 ... its Executive Board. Mr. Gert Weber has ... Invest AG as Chief Executive Officer (CEO) ... July 1 st , 2015. Mr. Weber brings more ... technological industries and has filled various executive management positions, ...
Breaking Medicine Technology:BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... 2011 Seal Shield LLC today announced ... for the iPad.  The product has been designed specifically ... use in hospital settings. The Seal Shield ... which is resistant to liquids including blood and bleach. ...
... MALVERN, Pa., Feb. 21, 2011 Today, Siemens (NYSE: ... Overhage, MD, PhD, as Chief Medical Informatics Officer (CMIO), of ... of the In diana Health Information Exchange ... this not-for-profit organization. In his role at Siemens, Marc will ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... sales training leaders Lora Posey (Manager, National Sales Training and Development) and Chuck ... Educators Network (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show ... July 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The ... a petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and ...
(Date:7/1/2015)... Humble, TX (PRWEB) , ... July 01, 2015 , ... ... also another symptom found in a significant number of women: leg pain. Northeast Houston ... , Leg pain, a symptom of venous reflux disease, is underdiagnosed and often ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning social policy often ... Professor in FIU’s School of International and Public Affairs. , The ... in the National Survey on Drug Use and Health, which is a nationally ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... contributing to newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights ... 1st and is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... Alzheimer's is the most common form of dementia in Canada, ... Statistics show that one in four people// over the age ... conducted by Dr. Peter St George-Hyslop who is a researcher ... is said that a single chemical in the brain is ...
... by Dutch researchers suggests that eating foods high in ... risk of developing motor neurone disease by 60 percent.// ... the Netherlands report their findings in the Journal of ... patients who had potential or definite amyotrophic lateral sclerosis ...
... of the cancers that results in death among the ... and a tablet// called Xeloda have only been given ... National Institute of Health and Clinical Excellence (NICE) issued ... patients who had cancerous tissue removed at an early ...
... poultry farms across the state of Chattisgarh have tested ... has not a single bird flu case as the ... High Security Animal Disease Lab at Bhopal," said Amir ... statement Thursday said the state government had been holding ...
... a vaccine for dust mite allergy sufferers.Dust mites found ... to other things//. They live in bedding, upholstered furniture ... the feces and body parts left by these insects. ... has claimed that their vaccine has been tested on ...
... Pennsylvania has begun offering "bloodless surgery" to almost 90% ... hospital now joins an ever-growing number of hospitals that ... country. ,This option was once only available ... hospitals to more patients thanks to the advances in ...
Cached Medicine News:
Naugle exophthalmometer is superior and inferior orbital rim-based instrument....
... easy-to-fit, daily disposable, spherical ... cast-mold technology, and designed ... correction of myopia and ... disposable contact lenses are ...
Both corneal topography and refractive error data are measured together in a single step to minimize alignment errors. Objective autorefractometry and autokeratometric readings of sphere, cylinder an...
... The only corneal topographer available ... optional built-in Pupillometer.,The German-engineered Keratograph delivers ... equally well for refractive surgery or ... exclusive optional infrared Pupillometer allows the ...
Medicine Products: